This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West

Savings Deadline Expires:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 18-21, 2025
San Diego Convention CenterSan Diego, CA, USA

Chiali Liu
Sr Director, Drug Substance Process Development Biologics CMC at Teva Pharmaceuticals
Speaker

Profile

Chiali Liu is Senior Director of Drug Substance Process Development, Biologics CMC at Teva Pharmaceuticals, overseeing upstream and downstream process development of biologic drug substance, technology transfer, and Material Sciences functions.

She obtained Ph.D. in Chemical Engineering at MIT.

She has more than 20 years’ experience in process development, scale-up, technology transfer, clinical and commercial production of biologics, plus technology transfer and commercialization of advanced therapy. She worked at Janssen, GSK, Human Genome Sciences, and Centocor before joining Teva.

Agenda Sessions

  • Fireside Chat: Continuous Vs Fed-Batch The Ongoing Debate

    11:50am
  • Late Breaking Scientific Presentation

    9:30am